Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Curaleaf Holdings, Inc. CURLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.02
+442.5%

Curaleaf Holdings, Inc. (CURLF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $2.40. It has a SharesGrow Score of 47/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Analyst consensus target is CURLF = $13 (+442.5% upside).

Financials: revenue is $1.3B, -1.1%/yr average growth. Net income is $235M (loss), growing at +13.2%/yr. Net profit margin is -18.2% (negative). Gross margin is 38.6% (-4.7 pp trend).

Balance sheet: total debt is $1.0B against $755M equity (Debt-to-Equity (D/E) ratio 1.37, moderate). Current ratio is 1.52 (strong liquidity). Debt-to-assets is 36.4%. Total assets: $2.8B.

Analyst outlook: 6 / 9 analysts rate CURLF as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 51/100 (Partial), Future 73/100 (Pass), Income 10/100 (Fail).

$13.02
▲ 442.5% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Curaleaf Holdings, Inc., the average price target is $13.02, with a high forecast of $23.87, and a low forecast of $6.25.
Highest Price Target
$23.87
Average Price Target
$13.02
Lowest Price Target
$6.25

CURLF SharesGrow Score Overview

55/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 51/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CURLF

✓
VALUE Pass
100/100
CURLF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $13, implying +441.7% from the current price $2. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
48/100
CURLF: -1.1%/yr revenue is, +13.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet CURLF: Debt-to-Equity (D/E) ratio 1.37 (moderate), Current ratio is 1.52 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
51/100
CURLF: Gross margin is 38.6% (-4.7 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 51/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
73/100
Analyst outlook: 6 / 9 analysts rate CURLF as buy (67%). Analyst consensus target is $13 (+441.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
CURLF: Net profit margin is -18.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.675-5.05
Volume64.35K
Avg Volume (30D)908.33K
Market Cap$1.86B
Beta (1Y)1.43
Share Statistics
EPS (TTM)-0.31
Shares Outstanding$762.09M
IPO Date2018-10-29
Employees5,519
CEOBoris Alexis Jordan
Financial Highlights & Ratios
Revenue (TTM)$1.29B
Gross Profit$498.2M
EBITDA$166.88M
Net Income$-235.12M
Operating Income$25.9M
Total Cash$101.39M
Total Debt$1.04B
Net Debt$933.83M
Total Assets$2.84B
Price / Earnings (P/E)-7.7
Price / Sales (P/S)1.44
Analyst Forecast
1Y Price Target$11.75
Target High$23.87
Target Low$6.25
Upside+389.6%
Rating ConsensusBuy
Analysts Covering9
Buy 67% Hold 33% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA23126M1023

Price Chart

Track all markets on TradingView
CURLF
Curaleaf Holdings, Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.68 52WK RANGE 5.05

People Also View

GTBIF
GTBIF
Green Thumb Industries Inc.
$6.76
+0.30%
 TCNNF
TCNNF
Trulieve Cannabis Corp.
$6.47
+2.73%
 CRON
CRON
Cronos Group Inc.
$2.57
+0.78%
 CRLBF
CRLBF
Cresco Labs Inc.
$0.92
+0.48%
 HEXO
HEXO
HEXO Corp.
$0.71
+2.45%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message